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AbstrACt
Introduction It is unclear whether advance care 
planning (ACP) undertaken with patients living in the 
community can improve patient care and avoid unwanted 
interventions and hospital admissions. We have designed 
a randomised controlled trial (RCT) to examine if ACP 
undertaken with patients with advanced illnesses 
attending hospital outpatient clinics can reduce unplanned 
hospital admissions and improve patient and caregiver 
well-being.
Methods and analysis Pragmatic RCT involving patients 
from subspecialty outpatient clinics at five clinical sites in 
Sydney, Australia. Participants will be ≥18 years screened 
as potentially having palliative care needs and at risk of 
dying in 6–12 months. The patients will be randomised 
to intervention or control group. Intervention group will 
undertake ACP discussions facilitated by a trained health 
professional. The control group will receive written 
information on ACP, representing the current standard of 
care. The primary outcome is the number of unplanned 
hospital admissions at the 6-month follow-up. Secondary 
outcomes include: (i) patient’s health-related quality-of-
life and quality of chronic disease care; (ii) caregiver’s 
health-related quality-of-life and caregiver burden and 
(iii) other health outcomes including ambulance usage, 
emergency department presentations, hospital admissions, 
resuscitation attempts, intensive care unit admissions, 
deaths, documentation of patient wishes in patient records 
and audit of ACP discussions and documents. The staff’s 
self-reported attitudes and knowledge of ACP will also 
be measured. The data will be collected using self-report 
questionnaires, hospital records audit, audit of ACP 
documentation and data linkage analysis. Semistructured 
interviews and focus group discussions with patients, 
caregivers and healthcare professionals will explore the 
acceptability and feasibility of the intervention.
Ethics and dissemination Approved by South-East 
Sydney Local Health District Human Research Ethics 
Committee and NSW Population and Health Services 
Research Ethics Committee. Results will be disseminated 
via conference presentations, journal publications, 
seminars and invited talks.
trial registration number ACTRN12617000280303.
IntroduCtIon  
Advance care planning (ACP) is a process 
of reflection, discussion and communica-
tion that enables a person to plan for their 
future medical treatment and other care 
for a time when they are not competent to 
make, or communicate, decisions for them-
selves.1 2 ACP can significantly improve the 
quality of care provided to patients with 
advanced illnesses,3 increase the chance of 
patient’s wishes being known and followed, 
improve emotional outcomes for the patient 
and caregivers and increase caregiver satisfac-
tion.4 5 There is also some evidence that ACP 
improves the patient’s quality of life,5 reduces 
ambulance use and unplanned hospital 
admissions6 7 and contributes to reduced 
patient mortality.6 
The importance of ACP in patient care has 
been widely recognised and endorsed by a 
large number of professional groups, specialist 
strengths and limitations of this study
 ► Due to its design as a pragmatic randomised con-
trolled trial in real-world conditions, the findings of 
the study are likely to be generalisable to clinical 
practice.
 ► Multiple sources of data including surveys of par-
ticipants, audit of medical records, health outcomes 
data obtained through data linkage and qualitative 
data (focus groups and interviews) will allow the 
study to examine the effectiveness of the interven-
tion on health outcomes, patient reported outcomes 
as well as its impact on health professionals and 
clinical services.
 ► The multiple sources of data will also allow trian-
gulation of the findings, especially health outcomes.
 ► The sample size takes into account the significant 
drop-out rate expected in the study due to with-
drawal and/or loss to follow-up and high mortality 
expected in the study patient population.
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colleges, peak bodies and patient advocate groups and in 
diverse clinical populations.8 In Australia, the National 
Health and Hospitals Reform Commission9 established 
by the Federal Government identified the importance of 
ACP and recommended its implementation on a national 
scale. The New South Wales (NSW) Ministry of Health 
created a policy on ACP;10 its priority is to incorporate 
ACP into routine care, to educate health professionals in 
both conducting and responding to ACP and to improve 
collaboration between NSW clinical services and commu-
nity and primary care health professionals.
Despite the wide recognition and endorsement, ACP 
is not commonly done in Australia.11 A chart audit 
conducted in 2006 in a large tertiary teaching hospital 
in Australia showed that none of 47 consecutive patients 
whose treatment was withdrawn in the intensive care unit 
had evidence of ACP.12 An older retrospective chart audit 
of 110 patients older than 65 years of age who died in a 
Sydney hospital showed the prevalence of Advance Care 
Plans (unclear but presumably informal documents) of 
7.3%.13 Studies from other Australian jurisdictions do not 
provide additional insights into the prevalence of ACP, 
except that it is very uncommon.1 14
Current evidence that ACP may lead to reduction in 
ambulance use and hospital admissions exists mainly in 
the residential aged care home setting.6 There is a lack 
of studies in Australia conducted in the community or 
outpatient settings, which examine the effect of ACP 
on unplanned hospital admissions or the use of acute 
health services. Busy emergency departments (EDs) and 
hospital wards are not ideal settings for ACP, and there is 
evidence that ACP decisions made when acutely unwell 
differ from decisions made when medically stable, so 
outpatient clinics are a better setting in which to conduct 
ACP.15 There is, however, lack of training and support for 
staff working in outpatient clinics to first identify patients 
who may benefit from ACP and second to facilitate ACP.
objECtIvE
The objective of this study is to determine whether a 
model of facilitated ACP intervention based in hospital 
outpatient clinics will reduce unplanned hospital admis-
sions and acute health services usage, improve the quality 
of care for patients and their caregivers/family and result 
in improved understanding and uptake of ACP by health 
professionals.
MEthods And AnAlysIs
study design and setting
This study is a pragmatic, prospective, multisite 
randomised controlled trial (RCT) with two parallel 
groups. It is a pragmatic RCT testing the real-world 
effectiveness of a complex intervention aimed at embed-
ding ACP into routine care provided by hospital outpa-
tient clinics. The study setting is subspecialty outpatient 
clinics (renal, cardiac, liver, respiratory, aged care and 
other relevant clinics) at five clinical sites across two 
Local Health Districts (LHDs) in Sydney, Australia: South 
East Sydney LHD (Prince of Wales Hospital, Sutherland 
Hospital, St George Hospital, War Memorial Hospital) 
and Sydney LHD (Concord Hospital).
Participants
To be eligible for the study, patients must be 18 years or 
older and attend an outpatient clinic of participating 
clinical services. They must be identified as potentially 
having supportive and palliative care needs and be at 
potential risk of dying in the next 6–12 months, as deter-
mined by the Supportive and Palliative Care Indicators 
Tool (SPICT).16 Patients must be interested in engaging 
in ACP as determined by the ACP screening tool17 and 
be willing and able to give written informed consent. If 
SPICT reveals that the patient has dementia or other 
illnesses that may impact on the patient’s decision-making 
capacity, then the treating medical team will determine 
if they have the capacity to provide informed consent. 
If they do not, then consent will be obtained from the 
person responsible (substitute decision-maker according 
to the hierarchy as defined by the NSW Guardianship Act 
1987), together with the patient.
Patients are not eligible for the trial if they are younger 
than 18 years of age, are pregnant or have both appointed 
an enduring guardian and made an advance care direc-
tive (ACD)/plan as determined by the ACP screening 
tool.17 Current inpatients or permanent residents of a resi-
dential aged care facility will be excluded from the study. 
Patients (or if a patient lacks decision making capacity, 
his/her guardian or person responsible) who are unable 
or unwilling to provide informed consent or are unable 
to provide informed consent and participate in ACP 
conducted in English due to difficulties in understanding 
and speaking English, also will be excluded. Figure 1 
describes the participant assessment and follow-up plan.
Intervention and control
Patients randomised to the control group will be provided 
written information on ACP, which represents the current 
standard care. The written information consists of: (1) 
ACP brochure produced by NSW Health,18 which contains 
basic information about ACP and where to get assis-
tance if interested; (2) ACP workbook endorsed by NSW 
Health;19 (3) Enduring Guardianship NSW booklet20 
and (4) Statement of Values and Wishes completed on 
behalf of the patient by their person responsible, when 
the patient is unable to develop an ACD.
The intervention group will be provided the same 
written information on ACP as the control group; however, 
ACP discussions will be actively facilitated by an ACP coor-
dinator or other trained health professional (table 1). 
This includes discussions with patients, caregivers, family 
and clinical staff, communications with other specialists, 
general practitioners (GPs) and other health providers 
involved in patient care, assistance with completing docu-
mentation and assistance with dissemination of ACP 
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documents, such as uploading them to the hospital elec-
tronic medical record system. The model of ACP used in 
the study has been in active clinical use for many years at 
several hospital sites that are taking part in the current 
study. It has been refined through active clinical practice, 
is approved by the hospital management and is widely 
accepted by the clinicians and patients.
Registered nurses from aged care, palliative care and 
chronic disease management background with interest 
and expertise in care coordination and ACP have been 
recruited as ACP coordinators for the project. They 
received face-to-face training in ACP and will be super-
vised by a Chief Investigator (AM) who is an expert in 
ACP and has conducted many training workshops. The 
three ACP coordinators will work closely with the staff of 
the participating outpatient clinics and will be responsible 
for initiating and conducting ACP discussions, answering 
questions from patients, caregivers and staff and assisting 
the patients with completion of ACDs and other docu-
ments. They will organise and facilitate meetings and 
teleconferences with clinical staff (eg, specialists and 
GPs) involved in the care of the patient and assist with 
dissemination of the completed documents using the 
hospital electronic medical records system and to GPs 
and specialists. The ACP coordinators will also provide 
education, training and mentorship to clinic staff, GPs 
and other health providers and help them incorporate 
ACP into routine care. The ACP coordinators will not 
have any other involvement in patient care.
Clinical staff ACP training
The clinical staff (medical, nursing, allied health) 
working in the participating outpatient clinics will receive 
education and training in ACP through lunchtime semi-
nars, workshops or unit meetings run by members of the 
research team and the project ACP coordinators. The 
training will use existing resources, such as Planning Ahead 
website (http:// planningaheadtools. com. au/), NSW 
Health endorsed ACP booklet,18 NSW Health documents 
and directives, such as the Using Resuscitation Plans in End 
Figure 1 Participant assessment and follow-up plan. ACP, advance care planning.  
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of Life Decisions document,21 and Health Education and 
Training Institute (HETI) training modules. Additional 
topics covered in the training will include legal liability 
and protection offered by Advance Care Plans and ACDs, 
capacity determination and hierarchy of decision-making 
in NSW.
Both the clinical staff training and the facilitated ACP 
intervention are informed by the Diffusion of Innovation 
Theory.22 This theory states that five conditions need to 
be met for innovation to be taken up: relative advantage, 
compatibility, complexity (how difficult the innovation 
appears), trialability and observability (whether positive 
outcomes of the innovation can be observed). This means 
that didactic education sessions alone are unlikely to be 
sufficient to lead to significant increase in ACP under-
taken by health professionals. For instance, compatibility 
with clinical service workflow or positive impact of ACP 
may not be readily apparent to busy clinicians, until 
they have experienced first-hand, ACP done with their 
patients. The study intervention allows staff members 
of clinical services to ‘see’ a few and ‘do’ a few, thereby 
increasing the chance of ACP being embedded into the 
routine care of patients.
Clinic staff will be initially invited to join ACP sessions 
facilitated by ACP coordinators (ie, ‘see’) in their clinical 
role (eg, as a doctor or nurse participant). After a few 
observations, clinic staff will be invited to facilitate ACP 
discussions (ie, ‘do’) with ACP coordinators observing 
and providing support. And finally, the clinic staff will 
conduct sessions independently with ACP coordinators 
providing telephone and email support. The precise 
details of how many clinic staff members undertake ‘see’ 
and ‘do’ will vary from clinic to clinic according to their 
staffing levels and available resources.
In addition, the research team will facilitate educa-
tional sessions for local GPs and other health profes-
sionals providing care for the patients enrolled in the 
study, in conjunction with the Central and Eastern Sydney 
Primary Health Network, an important partner in the 
study. ACP coordinators will also use their interactions 
with the patient’s GP or other health providers involved 
in the patient’s care as opportunities to promote ACP 
and for education. For instance, when they fax a copy of 
the patient’s ACD to the GP, this will be accompanied by 
an information sheet on ACP and the web address of the 
Planning Ahead website (http:// planningaheadtools. com. 
au).
Participant recruitment and enrolment
The outpatient clinic staff, either independently or with 
assistance from the ACP coordinators, will apply the 
SPICT16 to the patients attending the clinic that day. 
Having two or more general indicators, or one or more 
specific clinical indicators, will be taken as satisfying the 
Table 1 Elements of ACP interventions in RCT
Intervention group (facilitated ACP) Control group (current standard care)
Written information on ACP:
 ► ACP brochure produced by NSW Health18
 ► ACP workbook endorsed by NSW Health19
 ► Enduring Guardianship NSW booklet produced by the 
Public Guardian Office of the NSW Government Department 
of Attorney General & Justice20
 ► Statement of Values and Wishes completed on behalf of 
the patient by their person responsible (when the person is 
unable to develop an ACD) and supplemental information 
for families
Procedures, activities, processes delivered by ACP 
coordinators or ACP trained outpatient clinics staff:
 ► Provision of personalised information on ACP
 ► Facilitation of ACP discussions with patients, caregivers, 
family and relevant health professionals
 ► Assistance in completing appropriate ACP documents
 ► Referral to relevant local legal services for witnessing as 
required
 ► Organising and facilitating meetings and/or teleconferences 
with clinic staff, GPs and other healthcare professionals 
involved in patient’s care to discuss the patient’s care and 
their wishes
 ► Assistance with dissemination of ACP documents on 
completion that may include upload to LHD record system, 
national eHealth record (contingent on LHD and national 
eHealth improvements during the study period) and 
forwarding the document to patient’s GP
Written information on ACP:
 ► ACP brochure produced by NSW Health18
 ► ACP workbook endorsed by NSW Health19
 ► Enduring Guardianship NSW booklet produced by the 
Public Guardian Office of the NSW Government Department 
of Attorney General & Justice20
 ► Statement of Values and Wishes and supplemental 
information for families used for families to develop a plan 
(when the person is unable to develop an ACD)
ACP, advance care planning; LHD, Local Health District; NSW, New South Wales; RCT, randomised controlled trial. 
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SPICT criteria. Patients identified as meeting the SPICT 
criteria will be handed a 1-page brochure with informa-
tion about the project by the clinic staff on their arrival to 
the clinic appointment, unless the treating clinical team 
felt that it would be inappropriate to invite them to the 
study. Those expressing an interest in the study will be 
invited to meet with the ACP coordinator who will admin-
ister the ACP screening tool17 to assess whether a patient 
had previously been involved in ACP and if not then 
whether they are interested in engaging in ACP. Patients 
who had not been involved in ACP and were interested in 
ACP will be provided with further information about the 
study and invited to provide written informed consent. 
The ACP coordinator will check the inclusion and exclu-
sion criteria to make sure that the patient was eligible to 
participate in the trial. If SPICT reveals that the patient has 
dementia or other illness that may impact on the patient’s 
decision-making capacity, the treating medical team will 
be asked to determine if the patient has sufficient deci-
sion-making capacity to provide informed consent. If they 
do not, the person responsible will be invited to provide 
informed consent.
A participant will be enrolled into the study after the 
informed consent has been obtained and if the partici-
pant meets all inclusion criteria and does not meet any of 
the exclusion criteria. The participant will then complete 
a baseline patient questionnaire and nominate a caregiver 
to complete a baseline caregiver questionnaire. Following 
the completion of the enrolment questionnaires, the 
patient will be randomised to a control or intervention 
group.
Primary outcome
The primary outcome is the number of unplanned 
hospital admissions, defined as admissions or readmis-
sions with an overnight stay that were not previously 
planned or scheduled or ‘elective’,23 during the 6-month 
follow-up period. The data will be collected via an audit of 
the hospital records after the 6-month follow-up period.
secondary outcomes
Several secondary outcomes will be assessed at the 
6-month follow-up. The data will be collected using self-re-
port questionnaires, audit of hospital records, audit of 
ACP documentation and data linkage analysis (table 2).
Secondary outcomes assessed via self-reported surveys:
 ► Patient’s health related quality of life (SF-20).
 ► Patient’s reported quality of chronic disease care 
(PACIC).
 ► Caregiver’s health related quality of life (SF-20).
 ► Primary caregiver burden (ZBI-12).
 ► Clinical staff’s knowledge and attitudes to ACP.
Secondary outcomes measured using hospital records 
audits:
 ► Hospital admissions (unplanned and planned).
 ► ED presentations.
 ► Cardiopulmonary resuscitation (CPR) attempts.
 ► Documentation of ACDs and patient wishes in patient 
records.
Secondary outcomes measured using data linkage 
analysis:
 ► Ambulance services calls.
 ► ED presentations.
 ► Total number of hospital admissions.
 ► Date, place and causes of death.
 ► Resuscitation attempts.
 ► Intensive care unit admissions.
data collection and follow-up
Screening
Patient’s suitability for participation in the RCT will be 
assessed using the SPICT16 and the ACP Screening Inter-
view adapted from an original interview developed by 
Cheang et al.17 SPICT is a widely used tool that allows health 
and social care professionals to identify patients with 
advanced illnesses, who are potentially having supportive 
and palliative care needs and are at higher risk of death 
in the next 6–12 months. SPICT has six general indica-
tors of deteriorating health and clinical signs of advanced 
illnesses, such as congestive cardiac failure, chronic 
advanced respiratory illness that causes dyspnoea at rest or 
requires home oxygen, end stage renal failure, especially 
where dialysis has been stopped, advanced cirrhosis with 
complications such as hepatorenal syndrome and frailty. 
The modified version of the ACP Screening Interview will 
be used to determine whether patients have already been 
involved in ACP and if they have not, then whether they 
are interested in engaging in ACP.
Baseline data collection
The baseline enrolment questionnaire includes the 
patient’s basic demographic information including age, 
gender, marital status, employment status, country of 
birth, language spoken at home, Aboriginal or Torres 
Strait Islander heritage, level of education and whether 
they had a regular general practitioner. The patient’s 
caregiver will provide their own basic demographics data 
(age, gender, marital status, employment status, country 
of birth, language spoken at home, Aboriginal or Torres 
Strait Islander heritage and level of education) and the 
number of hours per week spent on caregiving duties. 
The clinic staff member will complete the Charlson 
Comorbidity Index (CCI)24 for the patient. The CCI is a 
validated measure of 1-year mortality risk and burden of 
disease, feasible in various healthcare settings. It consists 
of 17 comorbidities, including two subcategories for 
diabetes and liver disease, which are weighted from 1 to 6 
for mortality risk and disease severity and summed to the 
total CCI score.
Also at baseline as well as at the 6-month follow-up, 
self-report patient data will be collected on the health-re-
lated quality of life using the 20-Item Short Form Health 
Survey (SF-20)25 26 and the quality of chronic disease 
care using the Patient Assessment of Chronic Illness 
Care (PACIC).27 The SF-20 is a validated measure of 
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multiple health dimensions: physical functioning, role 
functioning, social functioning, mental health, percep-
tions of current health and pain. The SF-20 scores are 
transformed linearly to 0–100 scales, where 0 is the lowest 
possible score and 100, the highest possible score. The 
PACIC is a validated 20-item instrument to assess chronic 
illness patient’s experience in five domains of care: 
patient activation, delivery system design, goal setting, 
problem solving and follow-up/coordination. The score 
is obtained by summing participants’ responses across all 
20 items on a 5-point Likert scale, divided by 20. PACIC 
total scores range from 1 to 5; higher scores indicate 
patient’s perception of greater involvement in self-man-
agement and chronic care counselling.
Caregivers of patients will be asked to complete a 
self-report questionnaire focusing on their quality of 
life (SF-20) and caregiver burden (ZBI-12),28 at baseline 
and at the 6-month follow-up. The ZBI-12 is a validated 
instrument to provide brief and accurate assessment of 
caregiver burden. Each ZBI-12 item is a statement to be 
endorsed on a 5-point Likert scale (0—never, 4—nearly 
always); a higher score indicates a higher level of care-
giver burden.
Table 2 Study outcomes/variables, measurement tools and data collection schedule
Outcome/variable
Measurement tool/data 
source Validated Screener Baseline 6 months
Patients
  Supportive/palliative care needs SPICT ✓ ✓
  Previous ACP ACP Screening Tool ✓
  Contact information Purpose designed 
questionnaire
✓
  Demographics Purpose designed 
questionnaire
✓
  Comorbidity CCI ✓ ✓
  Health related quality of life SF-20 ✓ ✓ ✓
  Assessment of care for chronic 
conditions
PACIC ✓ ✓ ✓
  ACP discussion sessions* Audit of ACP discussion 
sessions*
✓
  ACP in the patient records Audit of hospital records ✓
  Hospital/ED admissions Audit of hospital records; 
data linkage
✓
  Ambulance service utilisations Data linkage ✓
  Health services utilisation Data linkage ✓
  Deaths Data linkage ✓
Caregiver
  Contact information Purpose designed 
questionnaire
✓
  Demographics Purpose designed 
questionnaire
✓
  Health related quality of life SF-20 ✓ ✓ ✓
  Caregiver burden ZBI-12 ✓ ✓ ✓
Clinical staff
  Contact information Purpose designed 
questionnaire
✓
  Demographics Purpose designed 
questionnaire
✓
  ACP attitudes, knowledge, 
confidence
Staff survey ✓ ✓ ✓
*Intervention group only; CCI: Charlson Comorbidity Index;23 PACIC: Patient Assessment of Chronic Illness Care;26 SF-20: 20-Item Short 
Form Health Survey;24 25 SPICT: Supportive and Palliative Care Indicators Tool;15 ZBI-12: Zarit Burden Short Form Interview.27
ACP, advance care planning; ED, emergency department.
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Clinical staff working in the outpatient clinics and 
participating in the ACP training will complete presur-
veys and postsurveys on ACP knowledge and attitudes. 
The survey consists of nine ACP knowledge items and 
nine items measuring beliefs, attitudes, experiences and 
perceived confidence and willingness of clinical staff to 
conduct ACP. The survey items were designed by a regis-
tered nurse and a GP with expertise in ACP and primary 
palliative care and tested in a study looking at ACP confi-
dence levels and motivation in practice nurses in a GP 
setting.29 The knowledge questions involve ‘yes/no’ 
questions and multiple choice questions and the attitude 
items are based on a five-point Likert scale with levels of 
agreement ranging ‘strongly disagree’ to ‘strongly agree’.
6-month data collection
At the 6-month follow-up, self-report patient data will be 
collected on the health-related quality of life (SF-20)25 26 
and the quality of chronic disease care (PACIC).27 Care-
givers of patients will be asked to complete a self-report 
questionnaire focusing on their quality of life (SF-20) and 
caregiver burden (ZBI-12).28 Clinical staff working in the 
outpatient clinics and participating in the ACP training 
will complete a 6-month follow-up survey on ACP knowl-
edge and attitudes.29
The 6-month follow-up involves an audit of ACDs 
(both intervention and control group) and an audit of 
ACP discussion sessions (intervention group only). The 
audit of ACD measures the output of ACP as indicated by 
the number and types of documents created as a result 
of ACP discussions. The audit of ACP discussion sessions 
involves collection of data on time taken; number of 
attendees and their categories (eg, patient, facilitator, 
family member, other healthcare professionals); number 
and types of documents completed; number and types 
of documents distributed; recommendations made to 
appoint substitute decision makers and referrals made to 
legal and specialist services.
The 6-month follow-up hospital records audits will 
collect data on planned and unplanned hospital admis-
sions, ED presentations, admission into the intensive care 
unit, cardiopulmonary resuscitation, major procedures 
and investigations, documentation of ACDs and patient 
wishes in patient records. Additionally, the following 
information will be collected through data linkage in 
collaboration with the Centre for Health Record Linkage 
(CHeReL): (1) ambulance services calls assessed by data 
linkage to NSW Ambulance Data Collection, (2) ED 
presentations assessed by data linkage to NSW Emergency 
Department Data Collection, (3) total number of hospital 
admissions assessed by data linkage to NSW Admitted 
Patient Data Collection, (4) date, place and causes of 
death assessed by data linkage NSW Mortality Data, 5) 
resuscitation attempts assessed by data linkage to NSW 
Emergency Department Data Collection, NSW Admitted 
Patient Data Collection, NSW Ambulance Data Collec-
tion and (6) Intensive Care Unit admissions assessed by 
data linkage to NSW Admitted Patient Data Collection.
At the 6-months mark, a small number of participants 
including patients, caregivers and healthcare profes-
sionals, will be invited to participate in semistructured 
interviews and focus groups. The interviews and focus 
groups will explore the acceptability and feasibility of the 
facilitated ACP process for patients, caregivers and clin-
ical staff. The study will also evaluate the ACD form and 
the accompanying information booklet used in the study. 
This evaluation will canvass the views of patients, their 
caregivers and health professionals about the usefulness 
and appropriateness of these documents as well as their 
recommendations for improving the template.
sample size
The sample size calculation is based on an assumed alpha 
of 0.05, power of 0.8 to detect at least 25% reduction (IRR 
0.75) in unplanned hospital admissions over 6 months 
(from an average of 2.2 over 6 months to 1.65 admissions 
over 6 months assuming the number of admissions follows a 
Poisson distribution in each group). Based on these assump-
tions, the study needs to recruit 100 people in each group, 
who will have the full 6-month follow-up, so that the number 
of hospitalisations in the groups are 220 (control) and 165 
(intervention). However, given that the expected death rate 
in the 6 months of the trial is up to 35%, the study needs to 
recruit 122 people in each arm of the trial. If the expected 
drop-out rate (withdrawal, loss to follow-up) is 15%, 144 
people are needed in each arm of the trial (in total n=288).
The estimated mean numbers of hospital admissions were 
obtained from a study conducted in Scotland16 which showed 
that patients with advanced renal, liver, cardiac and respira-
tory conditions identified by SPICT as at risk of dying within 
12 months had high hospital unplanned admission rates in 
the next 6 months (for patients alive, mean 2.2 admissions in 
6 months; for patients who have died, mean 2.4 admissions 
in last 6 months of life). This study also showed a death rate 
of 35% over a 6-month period. Effect size estimates for ACP 
in reducing admissions are based on a study by Caplan et al,6 
which showed that patients from nursing homes that had 
ACP programme had relative risk of hospital admission of 
0.74 compared with control homes. Molloy et al7 conducted 
a cluster RCT in Canadian nursing homes that showed that 
patients in nursing homes with ACP had mean admission 
rate of 0.27 per resident, compared with 0.48 for control 
homes over 18-month period. The effect size estimate of at 
least 25% reduction in admissions over 6 months is reason-
able when compared with these figures.
randomisation
Prior to randomisation, the patient participants are required 
to meet all the inclusion criteria and do not meet any of the 
exclusion criteria, screened using the ACP screening tool, 
provide written informed consent and complete the baseline 
questionnaire. Patients are randomised to either interven-
tion or control group using an online randomisation service 
( randomize. net). Randomisation is at the individual level 
by a computer generated random number sequence, in 
blocks of random sizes (4 and 6), in 1:1 ratio (control and 
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intervention). Stratification is according to the study site 
(hospital) and the number of hospital admissions in the past 
6 months (<2 vs 2 or more).
Study conducted by Highet et al16 showed significant 
differences in unplanned admission rates and death rates 
in patients who had <2 admissions in the 6 months prior to 
the study period compared with those who had 2 or more 
admissions. Due to the nature of the intervention, it is not 
possible to blind the patients participating in the study and 
clinical staff providing the ACP intervention, including ACP 
coordinators.
data analysis
Quantitative data
Descriptive statistics will be presented as proportions or 
means, with SD. Statistically significant difference in means 
between the intervention and control groups for continuous 
variables will be analysed using tests such as student’s t-test 
and analysis of variance. χ² and similar tests will be used to 
test statistical significance of categorical variables. Multi-
variate regression will be used to analyse the impact that 
independent variables may have on primary and secondary 
outcomes.
For the primary outcome (ie, number of unplanned 
hospital admissions during at 6-month follow-up), a Poisson 
regression model will be fitted, including follow-up time as an 
offset to compare the mean number of admissions between 
the trial arms. The analysis will also adjust for the variables 
used in stratification in the randomisation (number of 
admissions in 6 months prior to the trial and the study site). 
Secondary outcomes at 6 months, such as ambulance service 
calls, ED presentations, hospital admissions and other patient 
outcomes, will be analysed similarly to the primary outcome. 
Linear regression adjusting for stratification variables will be 
used to analyse other secondary outcomes at 6 months, such 
as health related quality of life, caregiver burden and assess-
ment of quality of chronic disease care. Descriptive statis-
tics will be used to analyse frequency of documentation of 
patient wishes in patient records, in the audit of SPICT, ACP 
screening tool forms completed by clinic staff and the ACDs 
and advance care plans completed during the study. Analysis 
of the results will be based on the initial group allocation, 
regardless of whether the intervention has been delivered 
in intervention participants or in the case of control group 
participants, whether they have engaged in ACP.
Patient and public involvement
The development of the research question and outcome 
measures was informed by the findings of the literature 
outlining the potential benefits that ACP can have on 
patients and caregivers. The study therefore includes 
multiple patient reported outcome measures as well as 
similar measures for the caregivers as well as a qualitative 
substudy to capture the experience of the patients and 
caregivers of being in the intervention and the control 
group.
Representatives from consumer organisations and 
patient advocacy groups are actively involved in the study 
steering group and have provided input into the study 
design and the conduct of the study.
A summary of the study findings will be provided to the 
study participants.
Ethics and dissemination
Ethics approval was obtained from the SESLHD Human 
Research Ethics Committee (HREC/16/POWH/654) 
and the NSW Population & Health Services Research 
Ethics Committee (2017/HRE1103). The trial has been 
registered with the Australian and New Zealand Clinical 
Trials Registry (Trial ID: ACTRN12617000280303). The 
study was approved by the NSW Population and Health 
Service Research Ethics Committee (2017/HRE1103) 
for the use of linked data owned or managed by NSW 
Ministry of Health, including the NSW Admitted Patient 
Data Collection and the NSW Emergency Department 
Data Collection.
Study results will be disseminated via reports to the 
funding body, academic presentations at conferences, 
journal publications and seminar sessions, workshops and 
invited talks.
dIsCussIon
The current study has been designed to determine whether 
a model of facilitated ACP intervention for patients with 
advanced illnesses attending hospital outpatient clinics can 
reduce unplanned hospital admissions and acute health 
services usage and improve the quality of care for patients 
and their caregivers/family. This study has several strengths 
and limitations which are presented below.
strengths
This RCT has a number of potential benefits. It may provide 
high-level (RCT) evidence that ACP conducted outside of the 
residential care home setting can lead to reduced unplanned 
hospital admissions and acute health services usage. Impor-
tantly, it could provide evidence that this can be achieved 
while at the same time improving patient quality of life, satis-
faction with care and reducing caregiver burden. Further, 
the proposed model of ACP has the potential to incorporate 
ACP into routine care of patients with advanced illnesses in 
outpatient clinics and by other health professionals involved 
in their care. This will be done by a process of diffusion, 
for instance, clinic staff are initially invited as participants 
in ACP discussions facilitated by trained ACP coordinators 
and as they gain experience and receive training and educa-
tion, they facilitate ACP independently. The delivery of the 
facilitated ACP intervention requires ongoing involvement 
of skilled clinical staff in a busy everyday clinical practice. 
Training and support, informed by the Diffusion of Innova-
tion Theory and provided in the study by the ACP coordina-
tors in clinical settings, should ensure quality and fidelity of 
the delivered intervention.
limitations
Significant drop-out rate due to withdrawal and/or loss 
to follow-up, and high mortality, is to be expected in an 
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intervention study of patients with advanced illnesses. This 
limitation has been taken into account in the calculation 
of an adequate sample size. In addition, the study excludes 
people whose English language skills are not adequate as 
documents were only available in English.
trial status
Recruitment for the study commenced in April 2017 and 
was completed in December 2017. The interventions were 
conducted between May 2017 and December 2017. The 
6-month follow-up (patient and caregiver questionnaires, 
audits) is expected to be completed by July 2018, with the 
data linkage extraction and analysis taking place in late 2018.
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